Publications by authors named "Paul Hourd"

Claim this Profile
T
The management of risk and investment in cell therapy process development: a case study for neurodegenerative disease.
Sujith Sebastian, Paul Hourd, Amit Chandra, David J Williams, Nicholas Medcalf

Regen Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scanning the horizon for high value-add manufacturing science: Accelerating manufacturing readiness for the next generation of disruptive, high-value curative cell therapeutics.
Paul Hourd, David J Williams

Cytotherapy· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 3D bioprinting exemplar of the consequences of the regulatory requirements on customized processes.
Paul Hourd, Nicholas Medcalf, Joel Segal, David J Williams

Regen Med· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparability: manufacturing, characterization and controls, report of a UK Regenerative Medicine Platform Pluripotent Stem Cell Platform Workshop, Trinity Hall, Cambridge, 14-15 September 2015.
David J Williams, Richard Archer, Peter Archibald, Ioannis Bantounas, Ricardo Baptista, Paul Hourd

Regen Med· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualification of academic facilities for small-scale automated manufacture of autologous cell-based products.
Paul Hourd, Amit Chandra, David Alvey, Patrick Ginty, Mark McCall

Regen Med· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving umbilical cord blood processing to increase total nucleated cell count yield and reduce cord input wastage by managing the consequences of input variation.
May Win Naing, Daniel A Gibson, Paul Hourd, Susana G Gomez, Roger B V Horton

Cytotherapy· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quality-by-design approach to risk reduction and optimization for human embryonic stem cell cryopreservation processes.
Peter D Mitchell, Elizabeth Ratcliffe, Paul Hourd, David J Williams, Robert J Thomas

Tissue Eng Part C Methods· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacturing models permitting roll out/scale out of clinically led autologous cell therapies: regulatory and scientific challenges for comparability.
Paul Hourd, Patrick Ginty, Amit Chandra, David J Williams

Cytotherapy· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stem cell isolation from human umbilical cord tissue: understanding and minimizing variability in cell yield for process optimization.
Andreea Iftimia-Mander, Paul Hourd, Roger Dainty, Robert J Thomas

Biopreserv Biobank· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of response surface methodology to maximize the productivity of scalable automated human embryonic stem cell manufacture.
Elizabeth Ratcliffe, Paul Hourd, Juan Guijarro-Leach, Erin Rayment, David J Williams

Regen Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Precision manufacturing for clinical-quality regenerative medicines.
David J Williams, Robert J Thomas, Paul C Hourd, Amit Chandra, Elizabeth Ratcliffe

Philos Trans A Math Phys Eng Sci· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regenerative medicine, resource and regulation: lessons learned from the remedi project.
Patrick J Ginty, Erin A Rayment, Paul Hourd, David J Williams

Regen Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human cell culture process capability: a comparison of manual and automated production.
Yang Liu, Paul Hourd, Amit Chandra, David J Williams

J Tissue Eng Regen Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Manufacture of a human mesenchymal stem cell population using an automated cell culture platform.
Robert James Thomas, Amit Chandra, Yang Liu, Paul C Hourd, Paul P Conway

Cytotechnology· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis